According to MyMD Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.45. In 2022 the company made an earnings per share (EPS) of -$0.51 an increase over its 2021 EPS that were of -$1.09.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.45 | -12.24% |
2022 | -$0.51 | -52.69% |
2021 | -$1.09 |